Therefore, the identification of TNF-α and CCL2 antagonists from natural sources would represent a new approach for the management of various chronic inflammatory conditions, including rheumatoid arthritis and cardiovascular diseases like arthrosclerosis [26, 36]. Here, TNF is linked to cardiovascular disorder.